Subcutaneous (SC) single dose

DRUG3 trials

Sponsors

GlaxoSmithKline, Arnatar Therapeutics, Inc., Medicsensors S.L

Conditions

AsthmaHealthyHypertension (HTN)

Phase 1

A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers

CompletedNCT01563042

GlaxoSmithKlineAsthma

Start: 2012-02-13End: 2012-05-23Updated: 2017-06-20

A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects

CompletedNCT07529600

Arnatar Therapeutics, Inc.Hypertension (HTN)

Start: 2024-01-18End: 2025-12-19Updated: 2026-04-14

Unknown Phase

Medicsen Smartpatch: Safety & Performance (SOUNDD)

Active, not recruitingNCT07615959

Medicsensors S.LHealthy

Start: 2026-01-20End: 2026-11-01Updated: 2026-05-29